Jonathan Bye
Lawyers
Filters
Pacific Biosciences $201.25 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
TTX $300 million medium-term note offering
The investment-grade notes are due 2052
Recursion Pharmaceuticals $150 million private placement
We advised the placement agents on the private placement of common stock
IDEAYA Biosciences $92 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Carvana $3.275 billion senior notes offering
The high-yield notes are due 2030
Carvana $1.25 billion follow-on offering
The shares are listed on the New York Stock Exchange
AN2 Therapeutics $69 million IPO
The shares are listed on the Nasdaq Global Select Market
Nurix Therapeutics $150 million at-the-market offering
We advised the sales agent on the stock offering
IDEAYA Biosciences $92 million follow-on offering
We advised the underwriters on the SEC-registered stock offering
RAPT Therapeutics $143.7 million follow-on offering
We advised the joint book-running managers on the SEC-registered equity offering